vs
Natural Grocers by Vitamin Cottage, Inc.（NGVC）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
Royalty Pharma plc的季度营收约是Natural Grocers by Vitamin Cottage, Inc.的1.9倍（$622.0M vs $335.6M），Royalty Pharma plc净利率更高（34.4% vs 3.4%，领先31.1%），Royalty Pharma plc同比增速更快（4.8% vs 1.6%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs 4.4%）
Natural Grocers by Vitamin Cottage, Inc.是美国本土的特色零售连锁企业，主营认证有机食品、膳食补充剂、天然个护及环保家居类产品，面向健康意识较强的消费群体，门店覆盖美国多州，执行严格品控标准，拒绝售卖含人工添加剂的商品。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
NGVC vs RPRX — 直观对比
营收规模更大
RPRX
是对方的1.9倍
$335.6M
营收增速更快
RPRX
高出3.2%
1.6%
净利率更高
RPRX
高出31.1%
3.4%
两年增速更快
RPRX
近两年复合增速
4.4%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $335.6M | $622.0M |
| 净利润 | $11.3M | $214.2M |
| 毛利率 | 29.5% | — |
| 营业利润率 | 4.4% | 62.4% |
| 净利率 | 3.4% | 34.4% |
| 营收同比 | 1.6% | 4.8% |
| 净利润同比 | 14.0% | 2.9% |
| 每股收益（稀释后） | $0.49 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NGVCRPRX
| Q4 25 | $335.6M | $622.0M | ||
| Q3 25 | $336.1M | $609.3M | ||
| Q2 25 | $328.7M | $578.7M | ||
| Q1 25 | $335.8M | $568.2M | ||
| Q4 24 | $330.2M | $593.6M | ||
| Q3 24 | $322.7M | $564.7M | ||
| Q2 24 | $309.1M | $537.3M | ||
| Q1 24 | $308.1M | $568.0M |
净利润NGVCRPRX
| Q4 25 | $11.3M | $214.2M | ||
| Q3 25 | $11.8M | $288.2M | ||
| Q2 25 | $11.6M | $30.2M | ||
| Q1 25 | $13.1M | $238.3M | ||
| Q4 24 | $9.9M | $208.2M | ||
| Q3 24 | $9.0M | $544.0M | ||
| Q2 24 | $9.2M | $102.0M | ||
| Q1 24 | $8.0M | $4.8M |
毛利率NGVCRPRX
| Q4 25 | 29.5% | — | ||
| Q3 25 | 29.5% | — | ||
| Q2 25 | 29.9% | — | ||
| Q1 25 | 30.3% | — | ||
| Q4 24 | 29.9% | — | ||
| Q3 24 | 29.6% | — | ||
| Q2 24 | 29.2% | — | ||
| Q1 24 | 29.3% | — |
营业利润率NGVCRPRX
| Q4 25 | 4.4% | 62.4% | ||
| Q3 25 | 4.6% | 70.1% | ||
| Q2 25 | 4.7% | 36.3% | ||
| Q1 25 | 5.2% | 94.0% | ||
| Q4 24 | 4.0% | 60.9% | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 4.2% | 50.2% | ||
| Q1 24 | 3.7% | -13.0% |
净利率NGVCRPRX
| Q4 25 | 3.4% | 34.4% | ||
| Q3 25 | 3.5% | 47.3% | ||
| Q2 25 | 3.5% | 5.2% | ||
| Q1 25 | 3.9% | 41.9% | ||
| Q4 24 | 3.0% | 35.1% | ||
| Q3 24 | 2.8% | 96.3% | ||
| Q2 24 | 3.0% | 19.0% | ||
| Q1 24 | 2.6% | 0.8% |
每股收益（稀释后）NGVCRPRX
| Q4 25 | $0.49 | $0.49 | ||
| Q3 25 | $0.51 | $0.67 | ||
| Q2 25 | $0.50 | $0.07 | ||
| Q1 25 | $0.56 | $0.55 | ||
| Q4 24 | $0.43 | $0.46 | ||
| Q3 24 | $0.38 | $1.21 | ||
| Q2 24 | $0.40 | $0.23 | ||
| Q1 24 | $0.35 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.2M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $220.0M | $9.7B |
| 总资产 | $668.6M | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资NGVCRPRX
| Q4 25 | $23.2M | $618.7M | ||
| Q3 25 | $17.1M | $938.9M | ||
| Q2 25 | $13.2M | $631.9M | ||
| Q1 25 | $21.2M | $1.1B | ||
| Q4 24 | $6.3M | $929.0M | ||
| Q3 24 | $8.9M | $950.1M | ||
| Q2 24 | $13.9M | $1.8B | ||
| Q1 24 | $11.0M | $843.0M |
总债务NGVCRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益NGVCRPRX
| Q4 25 | $220.0M | $9.7B | ||
| Q3 25 | $212.4M | $9.6B | ||
| Q2 25 | $202.5M | $9.5B | ||
| Q1 25 | $193.0M | $9.8B | ||
| Q4 24 | $181.9M | $10.3B | ||
| Q3 24 | $174.3M | $10.3B | ||
| Q2 24 | $167.8M | $9.8B | ||
| Q1 24 | $160.0M | $9.9B |
总资产NGVCRPRX
| Q4 25 | $668.6M | $19.6B | ||
| Q3 25 | $670.5M | $19.3B | ||
| Q2 25 | $659.0M | $18.3B | ||
| Q1 25 | $664.6M | $17.6B | ||
| Q4 24 | $648.9M | $18.2B | ||
| Q3 24 | $655.5M | $18.0B | ||
| Q2 24 | $654.4M | $17.7B | ||
| Q1 24 | $656.6M | $16.1B |
负债/权益比NGVCRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.1M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $11.6M | — |
| 自由现金流率自由现金流/营收 | 3.4% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 1.86× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $42.6M | — |
8季度趋势，按日历期对齐
经营现金流NGVCRPRX
| Q4 25 | $21.1M | $827.1M | ||
| Q3 25 | $15.6M | $702.6M | ||
| Q2 25 | $2.9M | $364.0M | ||
| Q1 25 | $34.1M | $596.1M | ||
| Q4 24 | $2.7M | $742.5M | ||
| Q3 24 | $24.5M | $703.6M | ||
| Q2 24 | $12.4M | $658.2M | ||
| Q1 24 | $20.2M | $664.6M |
自由现金流NGVCRPRX
| Q4 25 | $11.6M | — | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $-4.2M | — | ||
| Q1 25 | $27.6M | — | ||
| Q4 24 | $-6.9M | — | ||
| Q3 24 | $18.0M | — | ||
| Q2 24 | $3.6M | — | ||
| Q1 24 | $9.8M | — |
自由现金流率NGVCRPRX
| Q4 25 | 3.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | 8.2% | — | ||
| Q4 24 | -2.1% | — | ||
| Q3 24 | 5.6% | — | ||
| Q2 24 | 1.2% | — | ||
| Q1 24 | 3.2% | — |
资本支出强度NGVCRPRX
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.9% | — | ||
| Q1 24 | 3.4% | — |
现金转化率NGVCRPRX
| Q4 25 | 1.86× | 3.86× | ||
| Q3 25 | 1.32× | 2.44× | ||
| Q2 25 | 0.25× | 12.06× | ||
| Q1 25 | 2.60× | 2.50× | ||
| Q4 24 | 0.27× | 3.57× | ||
| Q3 24 | 2.72× | 1.29× | ||
| Q2 24 | 1.35× | 6.45× | ||
| Q1 24 | 2.54× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
